Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: A meta-analysis
T Yanagisawa, F Quhal, T Kawada, K Bekku… - …, 2023 - Taylor & Francis
Aim: To compare the efficacy of first-line immune checkpoint inhibitor (ICI)-based
combinations in metastatic renal cell carcinoma (mRCC) patients stratified by chronological …
combinations in metastatic renal cell carcinoma (mRCC) patients stratified by chronological …
Sex differences in cancer and immunotherapy outcomes: the role of androgen receptor
Across the wide range of clinical conditions, there exists a sex imbalance where biological
females are more prone to autoimmune diseases and males to some cancers. These …
females are more prone to autoimmune diseases and males to some cancers. These …
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations
L Incorvaia, FSM Monteiro, F Massari, SH Park… - Cancer Immunology …, 2024 - Springer
Background There is an ongoing debate as to whether sex could be associated with
immune checkpoint inhibitor (ICI) benefit. Existing literature data reveal contradictory results …
immune checkpoint inhibitor (ICI) benefit. Existing literature data reveal contradictory results …
Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic …
Background and objective Immune checkpoint inhibitors (ICIs) and antibody-drug
conjugates (ADCs) herald a transformative era in metastatic renal cell carcinoma (RCC) and …
conjugates (ADCs) herald a transformative era in metastatic renal cell carcinoma (RCC) and …
Relationship between sex and immune checkpoint inhibitors in urothelial carcinoma and renal cell carcinoma
Y Song, Y Peng, C Qin - World Journal of Urology, 2023 - Springer
We were interested to read the impressive study by Yanagisawa et al. in World Journal of
Urology [1] and would like to congratulate the authors for their interesting findings …
Urology [1] and would like to congratulate the authors for their interesting findings …
First-line therapy for metastatic renal cell carcinoma: A propensity score-matched comparison of efficacy and safety
T Yanagisawa, K Mori, T Kawada, S Katayama… - … Oncology: Seminars and …, 2024 - Elsevier
Purpose Immune checkpoint inhibitor (ICI)-based combination therapy is a standard
systemic treatment for metastatic renal cell carcinoma (mRCC). Although differential …
systemic treatment for metastatic renal cell carcinoma (mRCC). Although differential …
Letter to the editor for the article “Comparison between different neoadjuvant chemotherapy regimens and local therapy alone for bladder cancer: a systematic review …
Y Song, T Xu - World Journal of Urology, 2023 - Springer
We were interested to read the impressive study by Aydh et al. in World Journal of Urology
[1] and would like to congratulate the authors for their excellent findings about bladder …
[1] and would like to congratulate the authors for their excellent findings about bladder …
Gender aspects in urological disease
E Laukhtina - World Journal of Urology, 2023 - Springer
Gender-specific medicine has become increasingly important in identifying and
understanding differences in the ways diseases manifest in men and women. As our …
understanding differences in the ways diseases manifest in men and women. As our …
Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison …
M Santoni, G Roviello, E Grande, U Giorgi, O Fiala… - 2024 - researchsquare.com
Background The optimal first-line therapy for metastatic renal cell carcinoma (mRCC)
remains uncertain, despite recent advancements in immune-based combinations. This …
remains uncertain, despite recent advancements in immune-based combinations. This …
Assessing the Mechanisms Underlying the Association Between Sex and Immunotherapy Response in Lung Cancer
S Tavolacci - 2023 - search.proquest.com
Objectives: Immunotherapy has shown significant efficacy in treating advanced non-small
cell lung cancer. Whether sex is independently associated with differences in …
cell lung cancer. Whether sex is independently associated with differences in …